Literature DB >> 11451836

Clinical evaluation of the management of community-acquired pneumonia by general practitioners in France.

B Fantin1, J P Aubert, P Unger, H Lecoeur, C Carbon.   

Abstract

STUDY
OBJECTIVES: To evaluate the management of community-acquired pneumonia (CAP) by general practitioners (GPs) in terms of clinical efficiency and adherence to official recommendations.
DESIGN: Prospective cohort study.
SETTING: Community-based study from 11 French counties. PATIENTS: Adult patients clinically suspected of having CAP who were seen by GPs were included after confirmation of the presence of an infiltrate on chest radiographs. INTERVENTION: The management of the patients was left to the discretion of the GP. MEASUREMENTS AND
RESULTS: One hundred thirty patients were included in the study, and 13 patients (10%) were immediately hospitalized because of the severity of the pneumonia. The remaining 117 patients were treated as outpatients: 108 of 117 patients (92%) were cured, and 9 patients were subsequently hospitalized because of the failure of ambulatory treatment. Diagnostic error (n = 6) rather than antibiotic failure (n = 3) was the most frequent cause of the failure of ambulatory treatment. Only 40% of the patients received an initial antibiotic treatment that was in agreement with French recommendations. However, the rate of antibiotic failure leading to hospitalization was low (3 of 117 patients; 2.6%) and similar for patients treated or not according to recommendations (p > 0.5). Overall, five patients (4%) died; all deaths occurred during hospitalization and were related to the severity of the underlying disease but not to the choice of antibiotic treatment.
CONCLUSIONS: The management of CAP by GPs was clinically effective despite a poor adherence to official recommendations. Our results suggest that adequate assessment of severity rather than adherence to recommendations for antibiotic treatment had an impact on clinical outcome of CAP managed by GPs.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11451836     DOI: 10.1378/chest.120.1.185

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  6 in total

Review 1.  Community-acquired pneumonia: identification and evaluation of nonresponders.

Authors:  João Gonçalves-Pereira; Catarina Conceição; Pedro Póvoa
Journal:  Ther Adv Infect Dis       Date:  2013-02

2.  Cost-effectiveness of polysaccharide pneumococcal vaccination in people aged 65 and above in Poland.

Authors:  Pawel Grzesiowski; Raquel Aguiar-Ibáñez; Aleksandra Kobryń; Laure Durand; Pierre-Emmanuel Puig
Journal:  Hum Vaccin Immunother       Date:  2012-10-01       Impact factor: 3.452

Review 3.  The role of Streptococcus pneumoniae in community-acquired pneumonia among adults in Europe: a meta-analysis.

Authors:  M H Rozenbaum; P Pechlivanoglou; T S van der Werf; J R Lo-Ten-Foe; M J Postma; E Hak
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-12-14       Impact factor: 3.267

4.  Etiology of community-acquired pneumonia in a population-based study: link between etiology and patients characteristics, process-of-care, clinical evolution and outcomes.

Authors:  Alberto Capelastegui; Pedro P España; Amaia Bilbao; Julio Gamazo; Federico Medel; Juan Salgado; Iñaki Gorostiaga; Maria Jose Lopez de Goicoechea; Inmaculada Gorordo; Cristobal Esteban; Lander Altube; Jose M Quintana
Journal:  BMC Infect Dis       Date:  2012-06-12       Impact factor: 3.090

Review 5.  [Community acquired pneumonia CAP].

Authors:  Christoph Wenisch; Christine M Bonelli
Journal:  Wien Klin Wochenschr       Date:  2006-12       Impact factor: 1.704

6.  Use of intravenous antibiotics for the treatment of community-acquired pneumonia in the emergency department.

Authors:  Anita G Carrie; Thomas J Marrie
Journal:  Ther Clin Risk Manag       Date:  2005-03       Impact factor: 2.423

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.